Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2006

01-03-2006

Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc

Authors: Juan P. Oliva, Zodilina Valdés, Angel Casacó, Gilmara Pimentel, Joaquín González, Irene Álvarez, Martha Osorio, Milagros Velazco, Mariela Figueroa, Rosa Ortiz, Xiomara Escobar, Maiby Orozco, Julia Cruz, Sonia Franco, Mirtha Díaz, Lourdes Roque, Adriana Carr, Ana M. Vázquez, Cristina Mateos, María C. Rubio, Rolando Pérez, Luis E. Fernández

Published in: Breast Cancer Research and Treatment | Issue 2/2006

Login to get access
Metadata
Title
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc
Authors
Juan P. Oliva
Zodilina Valdés
Angel Casacó
Gilmara Pimentel
Joaquín González
Irene Álvarez
Martha Osorio
Milagros Velazco
Mariela Figueroa
Rosa Ortiz
Xiomara Escobar
Maiby Orozco
Julia Cruz
Sonia Franco
Mirtha Díaz
Lourdes Roque
Adriana Carr
Ana M. Vázquez
Cristina Mateos
María C. Rubio
Rolando Pérez
Luis E. Fernández
Publication date
01-03-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9064-0

Other articles of this Issue 2/2006

Breast Cancer Research and Treatment 2/2006 Go to the issue

Original Report

Use of raloxifene among women with a history of breast cancer

Preclinical study

High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model

OriginalPaper

Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women

Preclinical Study

EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer

Review

From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies

Preclinical study

Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits